Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2003
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP1305339A2 3d model of an fc epsilon receptor alpha chain-ige fc region complex
05/02/2003EP1305335A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
05/02/2003EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
05/02/2003EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305051A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
05/02/2003EP1305047A2 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
05/02/2003EP1305044A2 Qs-21 and il-12 as an adjuvant combination
05/02/2003EP1305041A1 Medicament for the immunotherapy of malignant tumours
05/02/2003EP1305019A2 Immunomodulatory compounds
05/02/2003EP1305006A2 Dispersions for formulating slightly or poorly soluble active ingredients
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1189611A4 Cancer therapy
05/02/2003EP1121375B1 High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
05/02/2003EP1071456B1 Vaccines with an ltb adjuvant
05/02/2003EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003EP0998272B1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
05/02/2003EP0993455B1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6] CYCLOHEPTA[1,2-b]PYRIDINE
05/02/2003EP0963371B1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
05/02/2003EP0948544B1 Monovalent antibody fragments
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0917647B1 Method of determining variations in the properties of a sample
05/02/2003EP0879294B1 Transduced human hematopoietic stem cells
05/02/2003EP0854874B1 Macrocyclic lactone compounds and their production process
05/02/2003EP0805628B1 Receptor specific transepithelial transport of immunogens
05/02/2003EP0775130B1 Method for the preparation of (+/-)-calanolide a and intermediates thereof
05/02/2003EP0772592B1 1H-INDOLE-1-FUNCTIONAL sPLA 2 INHIBITORS
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/02/2003EP0715519B1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
05/02/2003EP0672047B1 ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES
05/02/2003CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035836A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
05/01/2003WO2003035654A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003WO2003035653A1 Pyridothienopyrimidine compound and salt thereof
05/01/2003WO2003035650A1 Entry inhibitor
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035622A1 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents
05/01/2003WO2003035237A2 Compounds for use as surfactants
05/01/2003WO2003035108A1 Immunopotentiators in thermotherapy for cancer
05/01/2003WO2003035107A1 Enzyme inhibitors for inactivating allergens
05/01/2003WO2003035101A1 A method of treatment and agents useful for same
05/01/2003WO2003035100A1 Neuropilin as a novel therapeutic target for modulation of immune reponses
05/01/2003WO2003035090A1 Agents relieving anaphylactic allergic reactions and process for producing the same
05/01/2003WO2003035079A1 A combination product comprising melagatran and dexamethasone
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035068A1 Macrolides containing pharmaceutical compositions
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003035056A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003WO2003035037A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003WO2003035036A1 Montelukast granule formulation
05/01/2003WO2003035007A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
05/01/2003WO2003035004A2 Immunotherapy for reversing immune suppression
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003011223A3 Immunomodulatory compounds and methods of use thereof
05/01/2003WO2003008412A3 Hetero-bicyclic crf antagonists
05/01/2003WO2003002109A8 Use of tyrosine kinase inhibitors for treating autoimmune diseases
05/01/2003WO2002100351A3 A method for treating inflammatory diseases by administering a ppar-delta agonist
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002094247A3 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
05/01/2003WO2002090553A3 Recombinant fusion proteins and the trimers thereof
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002078741A3 Methods and compositions for modulating the immune system of animals
05/01/2003WO2002076483A3 Bacteriophage preparation
05/01/2003WO2002074806A3 New interferon beta-like molecules
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002070548A3 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
05/01/2003WO2002048165A3 Antiviral agents for treatment of flaviviridae infections
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2001096318A8 Cyclic urea compounds and preparation thereof
05/01/2003WO2001079291A3 Secreted proteins
1 ... 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 ... 1172